EP 3464339 A1 20190410 - B-TYPE NATRIURETIC PEPTIDE PROTEOLYTIC ASSAY FOR CARDIOVASCULAR DISEASE RISK ASSESSMENT
Title (en)
B-TYPE NATRIURETIC PEPTIDE PROTEOLYTIC ASSAY FOR CARDIOVASCULAR DISEASE RISK ASSESSMENT
Title (de)
PROTEOLYTISCHER TEST VON B-TYP-NATRIURETISCHEM PEPTID ZUR BEURTEILUNG DES RISIKOS VON HERZ-KREISLAUF-ERKRANKUNGEN
Title (fr)
DOSAGE PROTÉOLYTIQUE DU PEPTIDE NATRIURÉTIQUE DE TYPE B POUR L'ÉVALUATION DU RISQUE DE MALADIE CARDIOVASCULAIRE
Publication
Application
Priority
- US 201662345595 P 20160603
- US 2017035544 W 20170601
Abstract (en)
[origin: WO2017210488A1] Described herein are methods for assessing the risk of cardiovascular disease in a subject in need thereof by detecting the presence of one or more cleavage products of the one or more natriuretic peptides over a period of time, wherein the presence of one or more cleavage products is indicative of an increased risk of the subject developing cardiovascular disease.
IPC 8 full level
C07K 14/58 (2006.01); G01N 33/573 (2006.01); G01N 33/68 (2006.01); G01N 33/74 (2006.01)
CPC (source: EP)
C07K 14/58 (2013.01); C12Q 1/37 (2013.01); G01N 33/6893 (2013.01); G01N 33/74 (2013.01); G01N 2333/58 (2013.01); G01N 2800/325 (2013.01); G01N 2800/326 (2013.01); G01N 2800/50 (2013.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2017210488 A1 20171207; EP 3464339 A1 20190410; EP 3464339 A4 20191225
DOCDB simple family (application)
US 2017035544 W 20170601; EP 17807518 A 20170601